Avanos Medical (AVNS) Raw Materials (2014 - 2026)

Avanos Medical (AVNS) has 13 years of Raw Materials data on file, last reported at $4.0 million in Q1 2026.

• For the quarter ending Q1 2026, Raw Materials rose 25.0% year-over-year to $4.0 million; the trailing twelve-month figure through Mar 2026 stood at $4.0 million (up 25.0% YoY), and the FY2025 full-year result was $4.1 million, up 41.38% from the prior year.
• Raw Materials retreated to $4.0 million in Q1 2026, from $4.1 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $57.0 million in Q1 2023 to a low of $2.9 million in Q4 2024.
• A 5-year average of $18.2 million and a median of $4.8 million in 2024 frame the typical range for Raw Materials.
• Across the five-year window, Raw Materials tumbled 91.73% in 2024 and jumped 991.18% in 2025, its largest moves.
• Tracing AVNS's Raw Materials over 5 years: stood at $36.7 million in 2022, then slumped by 87.47% to $4.6 million in 2023, then slumped by 36.96% to $2.9 million in 2024, then surged by 41.38% to $4.1 million in 2025, then retreated by 2.44% to $4.0 million in 2026.
• Business Quant data shows AVNS's Raw Materials at $4.0 million in Q1 2026, $4.1 million in Q4 2025, and $37.1 million in Q3 2025.